Bharat Parenterals Limited has announced that its Board of Directors will convene on Tuesday, September 29, 2026. The primary agenda is to consider and evaluate the proposal for issuing equity shares or other eligible securities via a preferential issue.

Board Meeting Agenda

The board will assess the feasibility of the capital raise and approve the proposal if deemed fit. The meeting will also address other incidental business matters as required. This corporate action follows standard regulatory protocols for listed entities in India.

Trading Window Closure

In compliance with the company's Code of Conduct for regulating trading by designated persons, the trading window for dealing in Bharat Parenterals securities remains closed. The closure began on September 24, 2026, and will continue until 48 hours after the conclusion of the board meeting.

Regulatory Compliance

The intimation was filed under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice is available on the company's website and the BSE portal for public record.

Bharat Parenterals Limited concluded its 33rd Annual General Meeting on September 19, 2026. The meeting was held via video conferencing from its registered office in Vadodara, Gujarat.

Members approved the audited financial statements for the fiscal year ended March 31, 2026. The company also declared a final dividend for FY26 during the proceedings.

Key Resolutions Passed

The shareholders passed several ordinary resolutions during the meeting. Key decisions included the reappointment of board members and ratification of auditor fees.

Mr. Hemang Shah retires by rotation and offered himself for reappointment as Executive Director. Members approved his reappointment. The company also ratified the remuneration payable to M/S. CMA Chetan Gandhi, Cost Accountants, for the financial year ending March 31, 2027.

Meeting Proceedings

Mr. Bharatkumar Desai, Chairman & Managing Director, addressed the members. He provided an overview of the company’s financial performance and future outlook. The statutory auditors’ report dated May 18, 2026, and the secretarial auditors’ report dated August 5, 2026, were unqualified with no adverse observations.

Remote e-voting commenced on September 16, 2026, at 9:00 am and concluded on September 18, 2026, at 5:00 pm. E-voting was also available during the AGM for members present who had not voted remotely. M/S. Jigar Trivedi & Co acted as the scrutinizer for the voting process.

Voting Results Details

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed the details of voting results inclusive of remote e-voting and e-voting in relation to the 33rd Annual General Meeting (AGM) held on Saturday, September 19, 2026.

The meeting commenced at 11:00 am and concluded at 11:30 am through Video Conferencing (VC) / Other Audio Video Means (OAVM). All resolutions were passed with the requisite majority.

Mr. Sharmin Soni, Company Secretary & Compliance Officer, confirmed the results. The consolidated report of the Scrutinizer on remote e-voting and e-voting during the AGM was enclosed with the disclosure.